Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009256 |
---|---|
Receipt number | R000010868 |
Scientific Title | A phase 1 study of cisplatin/pemetrexed/crizotinib followed by maintenance crizotinib in patients with stage 3B or 4 EML4-ALK positive non-small-cell lung cancer. |
Date of disclosure of the study information | 2012/11/05 |
Last modified on | 2012/11/03 19:25:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/11/03 19:26:03 |